Donepezil Donepezil

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Donepezil on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

JP

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET;ORAL - 10MG
  • TABLET;ORAL - 5MG
  • TABLET, ORALLY DISINTEGRATING;ORAL - 10MG
  • TABLET, ORALLY DISINTEGRATING;ORAL - 5MG
  • TABLET;ORAL - 23MG
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8338485
Y
2025-11-22
206439
3
Abbvie Company Banner

ICRI Spring Convention

Not Confirmed

envelop Contact Supplier
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8293794
Y
2025-11-22
206439
2
Abbvie Company Banner

ICRI Spring Convention

Not Confirmed

envelop Contact Supplier
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8173708
2025-11-22
U-1641
Y
206439
MEMANTINE HCL/DONEPEZIL HCL COMBINATION FOR THE TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE
1
Abbvie Company Banner

ICRI Spring Convention

Not Confirmed

envelop Contact Supplier
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8039009*PED
2029-09-24